Roche Increases Investment in US Mfg Facility to $2 Bn 
By

By
Roche’s Genentech will more than double its initial investment in a biomanufacturing facility in Holly Springs, North Carolina, to approximately $2 billion, bolstering Roche’s and Genentech’s $50-billion investment in US manufacturing and R&D.   The expansion…

GSK To Acquire RAPT Therapeutics for $2.2 Bn 
By

By
GSK has agreed to acquire RAPT Therapeutics, a South San Franciso, California-based, clinical-stage bio/pharmaceutical company, for $2.2 billion.   The acquisition includes ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody, currently in Phase…

Shionogi Increasing Stake in ViiV Healthcare for $2.1 Bn; Pfizer Exits the HIV JV
By

By
GSK and Shionogi & Co., an Osaka-based bio/pharmaceutical company, have reached an agreement with Pfizer for Pfizer to sell its 11.7% stake in ViiV Healthcare, a joint venture between GSK,…

Supplier News: Apiject, Borealis Pharma, Sharp & Rentschler Biopharma 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Apiject, Borealis Pharma, Sharp & Rentschler Biopharma.   Formulation Development/Drug Product Manufacturing * Apiject Signs Lease for Blow-Fill-Seal Facility Packaging * Borealis Pharma Investing $57 M in Polypropylene Mfg Facility * Sharp…

Global Briefs: BMS, AstraZeneca, Pfizer, GSK & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Bristol Myers Squibb, AstraZeneca, Pfizer, GSK, Novo Nordisk, and Daiichi Sankyo.  For the latest news roundup on small and Emerging Pharma companies,…

Biotech Briefs: Agomab, Corxel Pharmaceuticals & More 
By

By
The latest from small and Emerging Pharma companies featuring Agomab Therpeutics, Corxel Pharmaceuticals, Insilico Medicine, Hygtia Therapeutics, Kuva Labs, Lisata Therapeutics, and Valneva  For news on the large and mid-sized bio/pharmaceutical companies, see…

AbbVie Announces Plans To Invest $100 Bn in US Mfg, R&D Over 10 Years
By

By
AbbVie has announced it will commit $100 billion in US research and development (R&D) and capital investments, including manufacturing, over the next decade (as reported on January 12, 2026). In…

Novartis To Build New Radioligand Mfg Facility as Part of $23-Bn US Investment Plan
By

By
Novartis has announced plans to build a new US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida. The facility represents another milestone in the company’s $23-billion US-based investments first…

Lilly, Nvidia in $1-Bn AI Pact
By

By
Eli Lilly and Company and Nvidia, the high-tech giant and producer of graphics processing units, systems on chips, and application programming interfaces for data science, high-performance/accelerated computing, and artificial intelligence…

White House Unveils Healthcare Plan To Lower Rx Drug Costs
By

By
President Donald Trump has issued a proposal, dubbed the Great Healthcare Plan, as a means to lower drug prices, reduce health insurance premiums and increase price transparency in the US…